P98 Proteomic of human normal articular chondrocytes  by unknown
$56 Poster  P resentat ions  
P98  
PROTEOMIC OF HUMAN NORMAL ARTICULAR 
CHONDROCYTES 
C Ruiz-Romero, MJ L6pez-Armada, FJ Blanco 
Osteoarticular and Aging Research Unit, Rheumatology 
Division, CH Universitario Juan Canalejo, A Coruha, Spain 
Introduction: Mitochondrias are involved in many cellular pro- 
cesses and mitochondrial dysfunctions have been associated 
with apoptosis, aging and number of pathological conditions, in- 
cluding osteoarthritis (OA). Mitochondrial proteins are an attrac- 
tive target to study the metabolism of chondrocyte and its role in 
the cartilage degradation. However, contaminating proteins has 
been the major problem in all the mitochondrial proteomic re- 
search. 
Aim: To obtain a Mitochondrial 2-DE proteome map of the human 
normal articular chondrocyte. To study whether purification of mi- 
tochondrias with density gradient ultracentrifugation using percoll 
and separation of proteins by 2D-E were useful to analysis the 
mitochondrial proteins of primary human normal articular chon- 
drocytes 
Material and Methods: Cells were isolated from five cartilages 
collected from autopsies without history of joint disease. Cul- 
tured cells were used to obtain different protein extracts (chon- 
drocytes: total chondrocyte extract (CE); cytosol-enriched frac- 
tion (CY); crude mitochondria fraction (CM) and purified mito- 
chondria fraction (PM)) which were resolved by 2-DE and vi- 
sualized by silver nitrate or Coomassie blue staining. Spots 
were excised from the gels and analyzed using matrix-assisted 
laser desorption/ionization-time of flight (MALDI-TOF) or MALDI- 
TOF/TOF mass spectrometry. 
Results: Results showed that purification of mitochondrias with 
density gradient ultracentrifugation using percoll and separation 
of proteins by 2D-E were useful to analysis the mitochondrial pro- 
teins of primary human normal articular chondrocytes. We iden- 
tified a total of 62 unambiguous proteins from 90 excised spots 
(69%) by means of peptide mass fingerprinting (PMF). The spots 
were excised from each of three 2D-E gels carrying proteins from 
the PM fraction. Further 4 samples that could not be recognized 
with the information available in the PMF were identified by tan- 
dem mass spectrometry using MALDI-TOF/TOF technology. All 
together, our analysis leads to the identification of 66 spots that 
represent 45 different proteins. Analysis of proteins showed that 
32% were located in the mitochondria, 15% in endoplasmic retic- 
ulum and 24% in the cytoplasm. According the biological function 
21% are involved in protein targeting, 11% in signalling, 11% in 
glycolisys, 11% RNA/DNA protein synthesis, 11% in OXPHOS 
and 4% in redox. During aging, the purified mitochondrial fraction 
of chondrocytes howed increases in antioxidative proteins such 
as SOMD. 
Conclusion: Because this technique allows the simultaneous 
identification and quantification of mitochondrial proteins in chon- 
drocytes, it may help to determine alterations in protein levels that 
occur in cartilage degradation associated with OA. 
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Aim of Study: Transglutaminases in articular cartilage ECM are 
responsible for retention and activation of latent TGFI~, and have 
been implicated in promotion of chondrocyte hypertrophy and 
CPPD crystal formation. TGases have been localized to the PCM 
of both normal and aging/OA chondrocytes, yet the role of TGase 
in the formation of healthy cartilage matrix and the organization 
of the chondrocyte pericellular matrix is not well understood. 
Methods: Porcine articular cartilage was harvested from com- 
mercially obtained knee joints. Enzymatically isolated chondro- 
cytes were grown in monolayer culture or in alginate beads in 
serum supplemented media containing monodansylcadaverine 
(MDC), or SY2011, a small competitive peptide inhibitor (PVKG). 
GAGs and type II collagen in collected media and GuHCI extracts 
were measured by DMMB assay or ELISA after 7 days. Cell via- 
bility was measured by MTT assay. Alginate bead cultures were 
aldehyde-fixed and dissolved after 3 days and chondrocytes were 
cast in thin agarose films. PCM were examined by immunocyto- 
chemistry using antibodies for types II and Vl collagen and fi- 
bronectin. 
Results: There was no change in GAG accumulation in media 
or cell-associated matrix by MDC at concentrations up to 50 I~M 
(p=0.48; n=5). A small decrease (25%; p=0.05) was seen at 100 
I~M. GAGs were unaffected by the peptide inhibitor SY2011 up to 
75 I~M. In contrast, concentration-dependent decreases in type 
II collagen were observed with both inhibitors. MDC reduced to- 
tal collagen accumulation by 21 and 27% at 12.5 and 25 I~M, 
respectively (p=0.017, 0.002), and at 100 I~M type II collagen 
was reduced by 65% (p=0.03). SY2011 lowered type II colla- 
gen production by 26% at 18.75 I~M (p=0.02) and 47% at 75 I~M 
(p=0.001) in a single experiment (4 replicates per group). Nei- 
ther MDC nor SY2011 shifted the distribution of GAGs or type II 
collagen from cell associated matrix to culture media. MDC de- 
creased cell viability only 6-10% (p~0.03); SY2011 had no effect 
at 18.75 and 37.5 I~M (p>0.1) but reduced viability by 12% at 
751~M (p=0.006). Chondrocytes had little or no ECM staining im- 
mediately after isolation. Some type Vl collagen and fibronectin 
staining was evident within 24 hours, and after three days, chon- 
drocytes had elaborated a PCM rich in type Vl and type II colla- 
gen. Fibronectin staining was mostly limited to the cell surface. 
MDC and SY2011, at their highest concentrations, did not inhibit 
the deposition of collagens in the PCM, and cell death was not 
apparent. 
Conclusions: Transglutaminase activity plays a significant part 
in the production of extracellular matrix by normal articular chon- 
drocytes; however, despite the reported co-localization of tissue 
transglutaminase with pericellular matrix molecules, a role for 
TGase in the organization/retention f the PCM is not supported 
by these results. 
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Background: Osteoarthritis is characterized by the progressive 
destruction of articular cartilage. Damage to the collagen net- 
work, one of the first signs of OA, is often considered irreversible, 
whereas proteoglycan loss is reversible. However, it was recently 
demonstrated that adult human cartilage does possess the ca- 
pacity to synthesize collagen and incorporate it correctly into the 
existing matrix. In addition, treatment of cartilage transplants with 
collagen-degrading enzymes, greatly enhances the integration 
into the surrounding recipient issue, indicating effective anabolic 
processes. These results open the possibility for the development 
of novel OA therapies directed at the modulation of collagen net- 
work formation. To fully appreciate the potential of this approach 
